Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

http://www.ubiasia.com.tw/News/Reasons%20to%20Choose%20Taiwan.pdf

I will now share with you our story of how UBI Asia came to be in partnership with
UBI, and the advantages for a high tech enterprise of being in Taiwan.
UBI is an international biopharmaceutical firm with cutting edge technology with
headquarters located on Long Island, New York. We at UBI are committed to treating
and preventing diseases by directing the immune system.
Our operational divisions are UBI-China in Beijing and Shanghai. UBI Asia in
Taiwan serves as our R&D center for Asia, and also provides cGMP manufacturing
facilities, both of which position us for growth in Asian and global markets

At UBI, we have combined elements of genomics and protein modeling
information with our expertise in immunology, synthetic chemistry, vaccine formulation,
and antibody engineering, to create our proprietary platform technologies in functional
antigenics. The company has used these proprietary technologies to develop a new
class of peptide-based immunotherapeutics, antibodies, and diagnostic products for
both human and animal health.
We have used our unique technologies to develop a pipeline of blockbuster
products for Alzheimer’s Disease, Prostate Cancer, AIDS, and Allergy with over 120
patents issued in the US and worldwide, and over 40 scientific publications, and
established product development and commercialization collaboration through
government sponsorship and global business alliances.